Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data.
暂无分享,去创建一个
Thomas Dierks | Friedhelm E Zanella | Heinrich Lanfermann | Wolfgang Schlote | Ulrich Pilatus | T. Dierks | W. Schlote | H. Lanfermann | F. Zanella | U. Pilatus | G. Marquardt | W. Möller-Hartmann | S. Herminghaus | Walter Möller-Hartmann | Gerhard Marquardt | Sebastian Herminghaus | Jörg Wittsack | Christoph Labisch | J. Wittsack | C. Labisch
[1] Y. Kinoshita,et al. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.
[2] M O Leach,et al. Introduction to in vivo MRS of cancer: new perspectives and open problems. , 1996, Anticancer research.
[3] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[4] A R Tate,et al. Towards a method for automated classification of 1H MRS spectra from brain tumours , 1998, NMR in biomedicine.
[5] R. Somorjai,et al. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.
[6] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[7] C B Begg,et al. Statistical methods in medical diagnosis. , 1986, Critical reviews in medical informatics.
[8] H Kalimo,et al. MR classification of brain gliomas: value of magnetization transfer and conventional imaging. , 1995, Magnetic resonance imaging.
[9] J. Voges,et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas , 1992, Annals of neurology.
[10] T. Hoshino. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. , 1984, Journal of neurosurgery.
[11] P. Pantano,et al. Supratentorial glioblastoma: Neuroradiological findings and survival after surgery and radiotherapy , 1996, Neuroradiology.
[12] F. Podo,et al. Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. , 1997, Acta neurochirurgica. Supplement.
[13] E. Squillaci,et al. MRI Atlas of Central Nervous System Tumors , 1991, Springer Vienna.
[14] Mark Noble,et al. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours , 1995, NMR in biomedicine.
[15] J E Heiserman,et al. Effect of voxel position on single-voxel MR spectroscopy findings. , 2000, AJNR. American journal of neuroradiology.
[16] B. Ross,et al. Short-Echo Time Proton MR Spectroscopy in the Presence of Gadolinium , 2001, Journal of computer assisted tomography.
[17] M. Brant-Zawadzki. Pitfalls of contrast‐enhanced imaging in the nervous system , 1991, Magnetic resonance in medicine.
[18] J. K. Smith,et al. Effects of contrast material on single-volume proton MR spectroscopy. , 2000, AJNR. American journal of neuroradiology.
[19] U. Nestle,et al. A Review of Current and Future Treatment Strategies for Malignant Astrocytomas in Adults , 2000, Strahlentherapie und Onkologie.
[20] E. Markakis,et al. Quantitative proton magnetic resonance spectroscopy of focal brain lesions. , 2000, Pediatric neurology.
[21] O. Schober,et al. Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with123I-α-methyl tyrosine and PET with18F-deoxyglucose , 1997, European Journal of Nuclear Medicine.
[22] I. Isherwood,et al. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain , 2004, Neuroradiology.
[23] O. H. Lowry,et al. DIVERSITY OF METABOLIC PATTERNS IN HUMAN BRAIN TUMORS—I. HIGH ENERGY PHOSPHATE COMPOUNDS AND BASIC COMPOSITION 1 , 1977, Journal of neurochemistry.
[24] P. Luyten,et al. Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.
[25] D. van Ormondt,et al. SVD-based quantification of magnetic resonance signals , 1992 .
[26] G. Chiro. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .
[27] J A Frank,et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.
[28] E. Shoubridge,et al. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.
[29] J. Ruíz-Cabello,et al. Phospholipid metabolites as indicators of cancer cell function , 1992, NMR in biomedicine.
[30] D Matthaei,et al. 1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.
[31] M Komiyama,et al. MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. , 1987, AJNR. American journal of neuroradiology.
[32] M Ala-Korpela,et al. Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. , 1996, Neuroreport.
[33] M. Décorps,et al. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. , 2001, Cancer research.
[34] F. Podo. Tumour phospholipid metabolism , 1999, NMR in biomedicine.
[35] T R Brown,et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.
[36] E. Ryding,et al. Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. , 1996, AJNR. American journal of neuroradiology.
[37] D. Louis Collins,et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.
[39] J R Griffiths,et al. Classification of tumour 1H NMR spectra by pattern recognition , 1992, NMR in biomedicine.
[40] J. Cooper,et al. N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.
[41] L D Lunsford,et al. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. , 1993, Journal of neurosurgery.
[42] J K Smith,et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. , 2001, AJNR. American journal of neuroradiology.
[43] O. Kizu,et al. Evaluation of metabolic heterogeneity in brain tumors using 1H‐chemical shift imaging method , 1997, NMR in biomedicine.
[44] C R Bird,et al. Gliomas: classification with MR imaging. , 1990, Radiology.
[45] J. Alger,et al. High‐field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy , 1989, Neurology.
[46] J. Pettegrew,et al. Analysis of magnetic resonance spectra by mole percent: Comparison to absolute units , 1994, Neurobiology of Aging.
[47] Ian C. P. Smith,et al. 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.
[48] H. Shimizu,et al. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. , 2000, AJNR. American journal of neuroradiology.
[49] M. Thelen,et al. Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. , 1988, Radiology.
[50] Peter Russell,et al. Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.
[51] R. Wurm,et al. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas , 2001, European Radiology.
[52] J A Frank,et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.
[53] K. Herholz,et al. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. , 1995, Radiology.
[54] E. Gotsis,et al. In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors. , 1996, Anticancer research.
[55] J R Griffiths,et al. An Investigation of Tumor 1H Nuclear Magnetic Resonance Spectra by the Application of Chemometric Techniques , 1992, Magnetic resonance in medicine.
[56] R. Kauppinen,et al. Choline‐Containing Compounds in Human Astrocytomas Studied by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of neurochemistry.